2017
DOI: 10.1016/j.imlet.2017.10.010
|View full text |Cite
|
Sign up to set email alerts
|

Inflammasomes and type 2 diabetes: An updated systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
57
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 76 publications
(58 citation statements)
references
References 90 publications
0
57
0
1
Order By: Relevance
“…As the important intracellular receptors, NLRs are supposed to participate in the induction of chronic inflammation in diabetes or its complications . The association between NLRP3 inflammasome and type 2 diabetes has been proved .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…As the important intracellular receptors, NLRs are supposed to participate in the induction of chronic inflammation in diabetes or its complications . The association between NLRP3 inflammasome and type 2 diabetes has been proved .…”
Section: Discussionmentioning
confidence: 99%
“…As the important intracellular receptors, NLRs are supposed to participate in the induction of chronic inflammation in diabetes or its complications . The association between NLRP3 inflammasome and type 2 diabetes has been proved . The latest studies have shown that aberrant activation of NLRP3‐inflammasomes was closely related to the development and prognosis of diabetes and its complications .…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…There was no limitation based on the date of study publications. The following index terms were used: "vitamin D" OR "vitamin D 2 " OR "vitamin D 3 " OR "cholecalciferol" OR "ergocalciferol" OR "calcitriol" OR "alfacalcidol" OR "paricalcitol" OR "doxercalciferol" OR "vitamin D analogues" OR "25-hydroxyvitamin D 2 " OR "25-hydroxyvitamin D 3 (25[OH]D 3 )" OR "hydroxycholecalciferol" OR "dihydrotachysterol" AND "type 2 diabetes" OR "prediabetes" AND "supplementation" AND "adipokine" OR "cytokine" OR "inflammation" OR "high-sensitivity C-reactive protein" OR "tumor necrosis factor" OR "interleukin". Reference lists and related records were manually reviewed.…”
Section: Literature Searchmentioning
confidence: 99%
“…According to the World Health Organization, there were approximately 415 million people with diabetes in the world, which could rise to 642 million by 2040 [1]. Type 2 diabetes mellitus (T2DM) is a chronic, progressive metabolic disease characterized by persistent hyperglycemia that is accompanied by chronic inflammation [2]. A growing body of evidence has suggested that high concentrations of circulating inflammatory biomarkers, such as interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α) and high-sensitivity C-reactive protein (hs-CRP), might play a critical role in the development of T2DM [3][4][5].…”
Section: Introductionmentioning
confidence: 99%